[Challace Pahlevan-Ibrekic]

Thank you,
Challace Pahlevan-Ibrekic, MBE, CIP
Director, Regulatory Affairs
Institute of Health System Science
130 East 59th Street, Suite 14C
New York, NY 10022
– Show quoted text -From: ***@***.***-groups.org on behalf of Francis P. Crawley via Artificial Intelligence and Data Visitation (AIDV) WG
Sent: Monday, October 9, 2023 6:39:26 AM
To: Artificial Intelligence and Data Visitation (AIDV) WG
Subject: [EXTERNAL] [rda-aidv-wg] Today’s EOSC-Future/RDA Artificial Intelligence and Data Visitation Working Group (AIDV-WG)
External Email. Do not click links or open attachments unless you trust the sender and content. Report suspicious emails using Report Phishing button or forward email to ***@***.***
Dear AIDV-WG Members,
The EOSC-Future/RDA Artificial Intelligence and Data Visitation Working Group (AIDV-WG) meets for our monthly meeting today from 14:00 to 15:00 CEST (Brussels/Paris time). The is the Zoom Link (Passcode 123).
The most important topics for us today are our deliverables. We have the following three in that need to be commented on and further developed.
[X]Informed Consent Guidance – Draft 2
[X]Deliverable 4 – Recommendations for REC-IRBs.docx
[X]AI Bill of Rights Team Deliverable
We are also waiting on the Deliverable 2 on legal aspects from Alexander and his team. And then too we need to discuss today again the survey.
While we need to have a strong focus now on the coordination, publication, exploitation, and implementation of our deliverables, we also need to start to look ahead at what we might want to do.
We had a rich discussion during our September monthly meeting on data visitation. We should take this forward. Perhaps in connection with this Shiny can report on the Belgian Day on Digital Twins in Healthcare in Leuven, Belgium that was held on Friday 29 September.
We have as our primary focus for reporting our deliverables the session on the RDA Plenary 21 at the IDW2023 Salzburg, Austria, 23-26 October 2023 – Our session is on Tuesday 24 October at UTC 14:00 – 15:30 | CEST/AT 16:00 – 17:30 | RDA P21 Breakout Session 3: Transforming the AIDV-WG’s deliverables into horizontal actions across data disciplines, sectors, and systems: Engaging digital communities in incorporating ELSI in data and AI tools and systems for achieving the UN SDGs and real-world outcomes You can register here.
We have applied for RDA Tiger Support in order to further help with our work going forward. We expect a final decision shortly.
I was required to submit by the end of September a Final Report on the EOSC-Future/RDA Artificial Intelligence & Data Visitation Working Group (AIDV-WG) to EOSC-Future, as the project ended then. Here is a link to the report. This is now we should now work on and refine together, perhaps for publication. Please add to it. Fix what is wrong. Revise. Perhaps just use ‘reviewing’ (track changes) so we can all follow.
Another thought was join a joint working group on ‘AI Policy for Science’ following on some recent publications. (Just a thought.)
1. The European Commission’s ‘Scoping Paper: Successful and timely uptake of Artificial Intelligence in science in the EU (4 July 2023)
2. OECD’s Artificial Intelligence in Science: Challenges, Opportunities and the Future of Research (June 2023)
3. ALLEA European Code of Conduct for Research Integrity (2023 revised edition [with AI])
Looking forward to being with everyone shortly.
Francis (also on behalf of Elif, Claudia, and Natalie)
—
Full post: https://www.rd-alliance.org/group/artificial-intelligence-and-data-visit…
Manage my subscriptions: https://www.rd-alliance.org/mailinglist
Stop emails for this post: https://www.rd-alliance.org/mailinglist/unsubscribe/78517
The information contained in this electronic e-mail transmission and any attachments are intended only for the use of the individual or entity to whom or to which it is addressed, and may contain information that is privileged, confidential and exempt from disclosure under applicable law. If the reader of this communication is not the intended recipient, or the employee or agent responsible for delivering this communication to the intended recipient, you are hereby notified that any dissemination, distribution, copying or disclosure of this communication and any attachment is strictly prohibited. If you have received this transmission in error, please notify the sender immediately by telephone and electronic mail, and delete the original communication and any attachment from any computer, server or other electronic recording or storage device or medium. Receipt by anyone other than the intended recipient is not a waiver of any attorney-client, physician-patient or other privilege.

Discussion